Philippa Marrack
Concepts (898)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes | 228 | 2021 | 2012 | 7.640 |
Why?
| | Receptors, Antigen, T-Cell | 114 | 2024 | 677 | 4.790 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 64 | 2024 | 330 | 4.770 |
Why?
| | Lymphocyte Activation | 76 | 2020 | 1137 | 4.250 |
Why?
| | Major Histocompatibility Complex | 58 | 2024 | 234 | 3.970 |
Why?
| | CD4-Positive T-Lymphocytes | 42 | 2024 | 1150 | 3.730 |
Why?
| | B-Lymphocytes | 65 | 2018 | 887 | 3.680 |
Why?
| | Thymus Gland | 61 | 2024 | 310 | 3.620 |
Why?
| | Histocompatibility Antigens Class II | 74 | 2021 | 365 | 3.500 |
Why?
| | Adjuvants, Immunologic | 14 | 2017 | 245 | 3.200 |
Why?
| | Autoimmunity | 17 | 2023 | 925 | 3.190 |
Why?
| | CD8-Positive T-Lymphocytes | 25 | 2021 | 931 | 2.710 |
Why?
| | Immunologic Memory | 28 | 2020 | 369 | 2.680 |
Why?
| | Histocompatibility Antigens | 18 | 2019 | 102 | 2.500 |
Why?
| | Mice | 320 | 2024 | 18297 | 2.290 |
Why?
| | Animals | 366 | 2024 | 38107 | 2.090 |
Why?
| | T-Lymphocyte Subsets | 22 | 2018 | 416 | 1.890 |
Why?
| | B-Lymphocyte Subsets | 8 | 2020 | 78 | 1.850 |
Why?
| | Antigens | 40 | 2020 | 350 | 1.810 |
Why?
| | Peptides | 43 | 2021 | 992 | 1.770 |
Why?
| | Alum Compounds | 7 | 2017 | 26 | 1.730 |
Why?
| | Proto-Oncogene Proteins | 13 | 2009 | 616 | 1.720 |
Why?
| | Apoptosis | 18 | 2018 | 2439 | 1.710 |
Why?
| | Mice, Inbred C57BL | 107 | 2024 | 6034 | 1.500 |
Why?
| | Immune Tolerance | 30 | 2021 | 386 | 1.480 |
Why?
| | Toll-Like Receptor 7 | 5 | 2016 | 43 | 1.400 |
Why?
| | T-Box Domain Proteins | 7 | 2020 | 106 | 1.380 |
Why?
| | Hybridomas | 73 | 2019 | 233 | 1.360 |
Why?
| | Dendritic Cells | 11 | 2017 | 509 | 1.360 |
Why?
| | Apoptosis Regulatory Proteins | 11 | 2011 | 186 | 1.330 |
Why?
| | Enterotoxins | 26 | 2009 | 89 | 1.310 |
Why?
| | Mice, Transgenic | 44 | 2024 | 2134 | 1.250 |
Why?
| | Aging | 11 | 2018 | 1996 | 1.160 |
Why?
| | Membrane Proteins | 12 | 2020 | 1130 | 1.130 |
Why?
| | Autoimmune Diseases | 11 | 2021 | 467 | 1.130 |
Why?
| | Superantigens | 20 | 2019 | 70 | 1.120 |
Why?
| | Autoantigens | 18 | 2021 | 426 | 1.110 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 13 | 2007 | 237 | 1.110 |
Why?
| | Antigen-Presenting Cells | 21 | 2015 | 161 | 1.100 |
Why?
| | H-2 Antigens | 38 | 2011 | 111 | 1.080 |
Why?
| | CD11c Antigen | 5 | 2020 | 40 | 1.060 |
Why?
| | Antigen Presentation | 16 | 2017 | 209 | 0.990 |
Why?
| | Antigens, Surface | 24 | 2011 | 155 | 0.950 |
Why?
| | Peptide Fragments | 18 | 2021 | 693 | 0.940 |
Why?
| | Amino Acid Sequence | 65 | 2019 | 2092 | 0.940 |
Why?
| | Immunity, Cellular | 15 | 2010 | 277 | 0.940 |
Why?
| | Vaccines | 4 | 2017 | 389 | 0.920 |
Why?
| | Spleen | 27 | 2016 | 503 | 0.910 |
Why?
| | Herpesviridae Infections | 3 | 2017 | 147 | 0.900 |
Why?
| | Immune System | 7 | 2013 | 181 | 0.900 |
Why?
| | Berylliosis | 5 | 2020 | 204 | 0.860 |
Why?
| | Autoantibodies | 7 | 2023 | 1500 | 0.860 |
Why?
| | Protein Binding | 31 | 2021 | 2244 | 0.850 |
Why?
| | Interleukin-2 | 38 | 2015 | 434 | 0.840 |
Why?
| | Mammary Tumor Virus, Mouse | 12 | 1995 | 42 | 0.840 |
Why?
| | Interleukin-12 | 2 | 2016 | 115 | 0.840 |
Why?
| | Epitopes | 46 | 2021 | 479 | 0.820 |
Why?
| | Clone Cells | 18 | 2008 | 259 | 0.820 |
Why?
| | Antigens, Viral | 10 | 2001 | 186 | 0.820 |
Why?
| | Interferon-gamma | 13 | 2016 | 781 | 0.810 |
Why?
| | Molecular Sequence Data | 60 | 2015 | 2838 | 0.800 |
Why?
| | Signal Transduction | 21 | 2018 | 5246 | 0.800 |
Why?
| | Gene Expression Regulation | 21 | 2015 | 2599 | 0.790 |
Why?
| | Immunoglobulin G | 8 | 2017 | 901 | 0.700 |
Why?
| | Cytokines | 16 | 2020 | 2081 | 0.680 |
Why?
| | Cell Survival | 18 | 2009 | 1105 | 0.640 |
Why?
| | Sarcoidosis, Pulmonary | 2 | 2020 | 100 | 0.640 |
Why?
| | Cell Differentiation | 31 | 2018 | 1982 | 0.630 |
Why?
| | Antibody Formation | 19 | 2017 | 290 | 0.630 |
Why?
| | Carrier Proteins | 11 | 2009 | 728 | 0.620 |
Why?
| | Genes, MHC Class II | 19 | 2014 | 77 | 0.610 |
Why?
| | Mice, Inbred BALB C | 48 | 2021 | 1244 | 0.610 |
Why?
| | Aluminum | 2 | 2010 | 43 | 0.600 |
Why?
| | Flow Cytometry | 26 | 2015 | 1163 | 0.600 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2020 | 96 | 0.600 |
Why?
| | Lymphocytes | 5 | 2018 | 379 | 0.590 |
Why?
| | Ovalbumin | 23 | 2011 | 187 | 0.580 |
Why?
| | Alleles | 12 | 2017 | 907 | 0.580 |
Why?
| | Cell Death | 15 | 2019 | 379 | 0.570 |
Why?
| | Mice, Inbred Strains | 36 | 2000 | 384 | 0.570 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2019 | 60 | 0.570 |
Why?
| | bcl-2-Associated X Protein | 5 | 2006 | 53 | 0.570 |
Why?
| | Natural Killer T-Cells | 6 | 2018 | 71 | 0.550 |
Why?
| | Mice, Knockout | 20 | 2017 | 3125 | 0.550 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 9 | 2017 | 846 | 0.550 |
Why?
| | Antibodies, Monoclonal | 53 | 2016 | 1512 | 0.550 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2020 | 642 | 0.540 |
Why?
| | CD8 Antigens | 10 | 2013 | 70 | 0.540 |
Why?
| | Lupus Erythematosus, Systemic | 3 | 2017 | 241 | 0.540 |
Why?
| | Cells, Cultured | 27 | 2019 | 4118 | 0.530 |
Why?
| | Thymocytes | 3 | 2018 | 33 | 0.530 |
Why?
| | Disease Susceptibility | 1 | 2019 | 339 | 0.520 |
Why?
| | Interleukin-4 | 6 | 2008 | 207 | 0.520 |
Why?
| | Interleukin-15 | 6 | 2013 | 96 | 0.510 |
Why?
| | Herpesviridae | 1 | 2017 | 21 | 0.510 |
Why?
| | Interleukin-7 | 4 | 2004 | 66 | 0.500 |
Why?
| | Epitopes, T-Lymphocyte | 6 | 2021 | 175 | 0.500 |
Why?
| | Amino Acids | 5 | 2022 | 515 | 0.500 |
Why?
| | Cell Line | 41 | 2021 | 2814 | 0.500 |
Why?
| | Cat Diseases | 1 | 2017 | 37 | 0.500 |
Why?
| | Bcl-2-Like Protein 11 | 9 | 2009 | 37 | 0.490 |
Why?
| | Friend murine leukemia virus | 1 | 2016 | 31 | 0.480 |
Why?
| | Deoxyribonucleases | 1 | 2016 | 24 | 0.480 |
Why?
| | Cell Proliferation | 12 | 2020 | 2502 | 0.470 |
Why?
| | Membrane Glycoproteins | 6 | 2013 | 495 | 0.470 |
Why?
| | Humans | 124 | 2023 | 146342 | 0.470 |
Why?
| | Homeostasis | 5 | 2007 | 646 | 0.470 |
Why?
| | Ikaros Transcription Factor | 2 | 2013 | 23 | 0.470 |
Why?
| | Cell Division | 11 | 2008 | 736 | 0.470 |
Why?
| | Antigens, Neoplasm | 5 | 2021 | 271 | 0.470 |
Why?
| | Models, Molecular | 26 | 2018 | 1574 | 0.460 |
Why?
| | Complementarity Determining Regions | 6 | 2011 | 54 | 0.460 |
Why?
| | Influenza A virus | 2 | 2013 | 120 | 0.430 |
Why?
| | Reactive Oxygen Species | 3 | 2003 | 610 | 0.430 |
Why?
| | Antigens, Bacterial | 8 | 2013 | 125 | 0.430 |
Why?
| | Evolution, Molecular | 4 | 2019 | 502 | 0.430 |
Why?
| | Histone Demethylases | 3 | 2020 | 39 | 0.420 |
Why?
| | Histocompatibility Antigens Class I | 10 | 2013 | 207 | 0.420 |
Why?
| | Immunity, Innate | 6 | 2019 | 844 | 0.410 |
Why?
| | Staphylococcus aureus | 12 | 1999 | 459 | 0.410 |
Why?
| | Protein Conformation | 19 | 2018 | 916 | 0.390 |
Why?
| | Models, Immunological | 8 | 2017 | 100 | 0.390 |
Why?
| | Clonal Deletion | 4 | 2004 | 16 | 0.390 |
Why?
| | Hypersensitivity | 2 | 2014 | 253 | 0.390 |
Why?
| | Gammaherpesvirinae | 1 | 2013 | 45 | 0.380 |
Why?
| | Nucleoproteins | 1 | 2013 | 37 | 0.380 |
Why?
| | Viral Proteins | 2 | 2009 | 351 | 0.380 |
Why?
| | Th2 Cells | 3 | 2010 | 179 | 0.380 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 82 | 0.370 |
Why?
| | DNA | 10 | 2016 | 1421 | 0.370 |
Why?
| | T-Lymphocytes, Cytotoxic | 5 | 2012 | 180 | 0.370 |
Why?
| | Base Sequence | 33 | 2015 | 2123 | 0.360 |
Why?
| | Lymphocyte Cooperation | 22 | 2006 | 50 | 0.360 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 129 | 0.360 |
Why?
| | Mutation | 22 | 2022 | 4093 | 0.360 |
Why?
| | Antigens, Differentiation, B-Lymphocyte | 3 | 2013 | 36 | 0.350 |
Why?
| | bcl-X Protein | 4 | 2006 | 44 | 0.340 |
Why?
| | Staphylococcus | 5 | 1994 | 74 | 0.340 |
Why?
| | Clonal Anergy | 3 | 2006 | 55 | 0.340 |
Why?
| | Antibodies | 7 | 2009 | 400 | 0.340 |
Why?
| | Binding Sites | 19 | 2021 | 1309 | 0.340 |
Why?
| | Receptors, Chemokine | 2 | 2008 | 47 | 0.330 |
Why?
| | Receptors, Cell Surface | 4 | 2020 | 371 | 0.330 |
Why?
| | Lipid A | 1 | 2011 | 27 | 0.330 |
Why?
| | Receptors, CXCR5 | 1 | 2011 | 29 | 0.330 |
Why?
| | Chromosomes, Human, X | 2 | 2015 | 76 | 0.330 |
Why?
| | Th1 Cells | 2 | 2010 | 139 | 0.330 |
Why?
| | Vaccines, Subunit | 1 | 2011 | 53 | 0.330 |
Why?
| | Female | 67 | 2021 | 79499 | 0.310 |
Why?
| | Germ Cells | 2 | 2016 | 67 | 0.310 |
Why?
| | Mast Cells | 2 | 2009 | 150 | 0.310 |
Why?
| | Minor Lymphocyte Stimulatory Antigens | 11 | 1993 | 22 | 0.310 |
Why?
| | Genes | 16 | 1990 | 215 | 0.300 |
Why?
| | Gonadal Steroid Hormones | 2 | 2014 | 143 | 0.300 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 2 | 2006 | 14 | 0.300 |
Why?
| | Inflammation | 5 | 2020 | 2919 | 0.300 |
Why?
| | Nobel Prize | 1 | 2009 | 6 | 0.300 |
Why?
| | Genetics, Medical | 1 | 2009 | 23 | 0.300 |
Why?
| | Cell Communication | 9 | 2013 | 327 | 0.300 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 89 | 0.290 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 17 | 1991 | 106 | 0.290 |
Why?
| | T-Cell Antigen Receptor Specificity | 3 | 2011 | 45 | 0.290 |
Why?
| | Glycoproteins | 3 | 2011 | 356 | 0.290 |
Why?
| | HLA-DR Antigens | 8 | 2008 | 211 | 0.280 |
Why?
| | Protein Processing, Post-Translational | 7 | 2018 | 487 | 0.280 |
Why?
| | Oligonucleotide Array Sequence Analysis | 5 | 2008 | 752 | 0.280 |
Why?
| | Receptors, Immunologic | 3 | 2020 | 210 | 0.280 |
Why?
| | Cytotoxicity, Immunologic | 7 | 2009 | 224 | 0.270 |
Why?
| | Cell Movement | 7 | 2017 | 951 | 0.270 |
Why?
| | Vaccination | 5 | 2010 | 1449 | 0.270 |
Why?
| | Allergy and Immunology | 2 | 2006 | 42 | 0.270 |
Why?
| | Herpesvirus 4, Human | 1 | 2009 | 172 | 0.270 |
Why?
| | Binding, Competitive | 8 | 2003 | 185 | 0.270 |
Why?
| | Transcription Factors | 5 | 2012 | 1730 | 0.260 |
Why?
| | Receptors, Interleukin-2 | 4 | 2003 | 64 | 0.250 |
Why?
| | CD3 Complex | 8 | 2009 | 113 | 0.250 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 2 | 2018 | 64 | 0.250 |
Why?
| | Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 4 | 2012 | 27 | 0.250 |
Why?
| | Bone Marrow Cells | 5 | 2016 | 328 | 0.250 |
Why?
| | HLA-DP beta-Chains | 4 | 2014 | 88 | 0.240 |
Why?
| | Genetic Predisposition to Disease | 4 | 2010 | 2488 | 0.240 |
Why?
| | Inflammation Mediators | 1 | 2009 | 508 | 0.240 |
Why?
| | T-Lymphocytes, Helper-Inducer | 10 | 1989 | 127 | 0.240 |
Why?
| | Gene Expression Profiling | 6 | 2018 | 1792 | 0.240 |
Why?
| | Histones | 3 | 2018 | 670 | 0.230 |
Why?
| | Transfection | 16 | 2008 | 916 | 0.230 |
Why?
| | RNA, Messenger | 11 | 2022 | 2791 | 0.230 |
Why?
| | Lymph Nodes | 14 | 2015 | 511 | 0.230 |
Why?
| | Diabetes Mellitus, Type 1 | 8 | 2021 | 3930 | 0.230 |
Why?
| | Bacterial Toxins | 6 | 1997 | 110 | 0.230 |
Why?
| | Lipopolysaccharides | 10 | 2005 | 861 | 0.230 |
Why?
| | History, 20th Century | 6 | 2016 | 330 | 0.230 |
Why?
| | Antigens, CD1d | 5 | 2013 | 69 | 0.220 |
Why?
| | Gene Expression | 11 | 2017 | 1463 | 0.220 |
Why?
| | Cross Reactions | 8 | 2012 | 130 | 0.220 |
Why?
| | Cytochrome c Group | 5 | 2002 | 43 | 0.220 |
Why?
| | Cell Membrane | 6 | 2004 | 701 | 0.210 |
Why?
| | Protein Folding | 1 | 2006 | 281 | 0.210 |
Why?
| | NF-kappa B | 3 | 2017 | 674 | 0.210 |
Why?
| | Heterozygote | 2 | 2024 | 311 | 0.210 |
Why?
| | Immunoglobulin Variable Region | 11 | 2012 | 78 | 0.210 |
Why?
| | Baculoviridae | 7 | 2015 | 44 | 0.210 |
Why?
| | Histiocytosis, Non-Langerhans-Cell | 1 | 2004 | 5 | 0.210 |
Why?
| | Repressor Proteins | 2 | 2015 | 430 | 0.210 |
Why?
| | Beryllium | 3 | 2014 | 163 | 0.210 |
Why?
| | Neoplasms, Experimental | 3 | 2021 | 163 | 0.200 |
Why?
| | Insulin | 4 | 2019 | 2525 | 0.200 |
Why?
| | Cell Separation | 12 | 2008 | 300 | 0.200 |
Why?
| | Mitochondria | 4 | 2008 | 997 | 0.200 |
Why?
| | Lymphokines | 13 | 1984 | 127 | 0.200 |
Why?
| | Interleukin-6 | 3 | 2011 | 784 | 0.200 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 2 | 2001 | 15 | 0.190 |
Why?
| | Positive Transcriptional Elongation Factor B | 2 | 2020 | 28 | 0.190 |
Why?
| | Crystallography, X-Ray | 9 | 2018 | 477 | 0.190 |
Why?
| | Lysosomes | 2 | 2021 | 134 | 0.190 |
Why?
| | Genes, bcl-2 | 1 | 2002 | 21 | 0.190 |
Why?
| | Chromogranin A | 2 | 2015 | 43 | 0.190 |
Why?
| | Chemokine CCL5 | 1 | 2002 | 40 | 0.190 |
Why?
| | Oligopeptides | 2 | 2001 | 264 | 0.190 |
Why?
| | beta 2-Microglobulin | 4 | 2010 | 47 | 0.180 |
Why?
| | Clodronic Acid | 1 | 2002 | 19 | 0.180 |
Why?
| | Anemia, Hemolytic, Autoimmune | 1 | 2002 | 17 | 0.180 |
Why?
| | Polymorphism, Genetic | 6 | 2012 | 612 | 0.180 |
Why?
| | Cloning, Molecular | 13 | 2017 | 526 | 0.180 |
Why?
| | Radiation Chimera | 4 | 2001 | 28 | 0.180 |
Why?
| | Ubiquitin-Protein Ligases | 3 | 2008 | 198 | 0.180 |
Why?
| | Concanavalin A | 17 | 1990 | 72 | 0.180 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2002 | 92 | 0.180 |
Why?
| | Egg Proteins | 1 | 2001 | 14 | 0.170 |
Why?
| | T-Lymphocytes, Regulatory | 5 | 2017 | 415 | 0.170 |
Why?
| | Cell Culture Techniques | 2 | 2001 | 371 | 0.170 |
Why?
| | Ligands | 9 | 2022 | 678 | 0.170 |
Why?
| | Moloney murine leukemia virus | 1 | 2001 | 12 | 0.170 |
Why?
| | Mice, Mutant Strains | 7 | 2008 | 290 | 0.170 |
Why?
| | Lung Diseases | 2 | 2010 | 787 | 0.170 |
Why?
| | Transcription, Genetic | 7 | 2020 | 1432 | 0.170 |
Why?
| | Protein Structure, Tertiary | 8 | 2021 | 834 | 0.170 |
Why?
| | Interferon-alpha | 4 | 2014 | 201 | 0.170 |
Why?
| | Open Reading Frames | 3 | 1992 | 130 | 0.170 |
Why?
| | B7-1 Antigen | 3 | 2004 | 55 | 0.170 |
Why?
| | Transduction, Genetic | 1 | 2001 | 129 | 0.170 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2006 | 1224 | 0.170 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 1992 | 116 | 0.170 |
Why?
| | Cathepsins | 1 | 2021 | 24 | 0.160 |
Why?
| | Immunoglobulin Idiotypes | 7 | 1986 | 28 | 0.160 |
Why?
| | HLA-C Antigens | 1 | 2021 | 37 | 0.160 |
Why?
| | Macromolecular Substances | 16 | 2003 | 205 | 0.160 |
Why?
| | Receptors, Fc | 2 | 2020 | 54 | 0.160 |
Why?
| | Chimera | 8 | 2009 | 62 | 0.160 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2004 | 429 | 0.160 |
Why?
| | Self Tolerance | 3 | 2017 | 27 | 0.160 |
Why?
| | Immunity | 3 | 2007 | 141 | 0.160 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2022 | 992 | 0.160 |
Why?
| | HLA-DQ Antigens | 2 | 2019 | 171 | 0.160 |
Why?
| | Models, Animal | 1 | 2002 | 387 | 0.160 |
Why?
| | Immunity, Humoral | 2 | 2022 | 121 | 0.160 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2020 | 17 | 0.160 |
Why?
| | Genetic Vectors | 2 | 2001 | 327 | 0.160 |
Why?
| | Macrophages | 18 | 2002 | 1532 | 0.160 |
Why?
| | Hematopoietic Stem Cells | 4 | 2014 | 432 | 0.160 |
Why?
| | Interferon-beta | 3 | 2007 | 90 | 0.150 |
Why?
| | Mice, Inbred NOD | 7 | 2019 | 598 | 0.150 |
Why?
| | RNA Polymerase II | 2 | 2020 | 347 | 0.150 |
Why?
| | Transcription Factor AP-1 | 1 | 2000 | 76 | 0.150 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 250 | 0.150 |
Why?
| | Lymphocytic choriomeningitis virus | 2 | 2011 | 36 | 0.150 |
Why?
| | Receptors, Complement 3d | 1 | 2020 | 150 | 0.150 |
Why?
| | Sex Characteristics | 3 | 2015 | 801 | 0.150 |
Why?
| | Genome | 2 | 2000 | 307 | 0.150 |
Why?
| | Kidney | 2 | 2017 | 1498 | 0.150 |
Why?
| | Methyltransferases | 1 | 2020 | 74 | 0.150 |
Why?
| | Peptide Library | 4 | 2013 | 91 | 0.150 |
Why?
| | Crosses, Genetic | 7 | 2006 | 120 | 0.150 |
Why?
| | Disease Models, Animal | 6 | 2014 | 4580 | 0.150 |
Why?
| | Vaccinia | 1 | 1999 | 20 | 0.150 |
Why?
| | CD28 Antigens | 2 | 2008 | 57 | 0.140 |
Why?
| | fas Receptor | 4 | 2002 | 91 | 0.140 |
Why?
| | Trans-Activators | 2 | 2000 | 372 | 0.140 |
Why?
| | Caspase 1 | 2 | 2009 | 145 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2020 | 3647 | 0.140 |
Why?
| | Adaptive Immunity | 2 | 2017 | 173 | 0.140 |
Why?
| | Mass Spectrometry | 3 | 2020 | 729 | 0.140 |
Why?
| | Lymphocyte Count | 4 | 2010 | 167 | 0.140 |
Why?
| | Mice, Inbred DBA | 19 | 2002 | 186 | 0.140 |
Why?
| | Nickel | 2 | 2012 | 63 | 0.140 |
Why?
| | Adoptive Transfer | 6 | 2015 | 197 | 0.130 |
Why?
| | Dose-Response Relationship, Immunologic | 11 | 2000 | 77 | 0.130 |
Why?
| | Germinal Center | 2 | 2017 | 67 | 0.130 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2009 | 167 | 0.130 |
Why?
| | Complement C3b Inactivator Proteins | 1 | 2017 | 9 | 0.130 |
Why?
| | Minor Histocompatibility Antigens | 2 | 2015 | 47 | 0.130 |
Why?
| | Interferon Type I | 1 | 1999 | 147 | 0.130 |
Why?
| | Male | 30 | 2020 | 73396 | 0.130 |
Why?
| | Receptors, Interferon | 2 | 2013 | 60 | 0.130 |
Why?
| | Immunotherapy | 3 | 2021 | 671 | 0.130 |
Why?
| | Antigens, CD | 4 | 2000 | 560 | 0.130 |
Why?
| | Neoplasms | 3 | 2021 | 2954 | 0.130 |
Why?
| | CD4 Antigens | 9 | 1998 | 136 | 0.130 |
Why?
| | Retinal Pigment Epithelium | 1 | 2017 | 81 | 0.130 |
Why?
| | Time Factors | 10 | 2013 | 7109 | 0.130 |
Why?
| | Blotting, Western | 3 | 2020 | 1177 | 0.120 |
Why?
| | Receptors, IgE | 1 | 1997 | 43 | 0.120 |
Why?
| | Substrate Specificity | 1 | 2017 | 389 | 0.120 |
Why?
| | Complement Factor H | 1 | 2017 | 81 | 0.120 |
Why?
| | Mice, Inbred C3H | 8 | 1993 | 252 | 0.120 |
Why?
| | Complement Pathway, Alternative | 1 | 2017 | 123 | 0.120 |
Why?
| | Cats | 1 | 2017 | 226 | 0.120 |
Why?
| | Phenotype | 9 | 2008 | 3206 | 0.120 |
Why?
| | Drug Contamination | 1 | 2016 | 56 | 0.120 |
Why?
| | Amino Acid Motifs | 6 | 2019 | 218 | 0.120 |
Why?
| | Lupus Nephritis | 4 | 2012 | 67 | 0.120 |
Why?
| | Graft Rejection | 3 | 2015 | 516 | 0.110 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2016 | 119 | 0.110 |
Why?
| | Immunization | 8 | 2013 | 376 | 0.110 |
Why?
| | HLA Antigens | 3 | 2013 | 241 | 0.110 |
Why?
| | Hematopoiesis | 1 | 1997 | 195 | 0.110 |
Why?
| | Down-Regulation | 3 | 2003 | 614 | 0.110 |
Why?
| | Chemokine CCL19 | 1 | 2015 | 5 | 0.110 |
Why?
| | Serum Albumin, Bovine | 5 | 2011 | 63 | 0.110 |
Why?
| | Chemokine CCL21 | 1 | 2015 | 13 | 0.110 |
Why?
| | Immunoconjugates | 1 | 1997 | 138 | 0.110 |
Why?
| | Immunoglobulin Isotypes | 2 | 2008 | 36 | 0.110 |
Why?
| | Receptors, CCR7 | 1 | 2015 | 32 | 0.110 |
Why?
| | Genetic Linkage | 8 | 2002 | 271 | 0.110 |
Why?
| | Imidazoles | 1 | 2016 | 245 | 0.110 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 96 | 0.110 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2015 | 43 | 0.110 |
Why?
| | Sequence Homology, Nucleic Acid | 7 | 1992 | 157 | 0.110 |
Why?
| | Skin Transplantation | 1 | 2015 | 77 | 0.110 |
Why?
| | Nicotine | 1 | 2017 | 337 | 0.110 |
Why?
| | Antiviral Agents | 1 | 2021 | 779 | 0.110 |
Why?
| | Thymoma | 4 | 2012 | 38 | 0.110 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 348 | 0.100 |
Why?
| | Immunoglobulin Heavy Chains | 6 | 1988 | 83 | 0.100 |
Why?
| | Epithelium | 6 | 1997 | 295 | 0.100 |
Why?
| | Macrophages, Alveolar | 1 | 2017 | 377 | 0.100 |
Why?
| | Green Fluorescent Proteins | 3 | 2013 | 408 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 974 | 0.100 |
Why?
| | Mycobacterium tuberculosis | 1 | 2017 | 325 | 0.100 |
Why?
| | Granuloma | 1 | 2014 | 96 | 0.100 |
Why?
| | Hybridization, Genetic | 2 | 2014 | 75 | 0.100 |
Why?
| | Molecular Weight | 11 | 2006 | 295 | 0.100 |
Why?
| | Organ Culture Techniques | 6 | 1993 | 150 | 0.100 |
Why?
| | Fluorescent Antibody Technique | 4 | 2004 | 345 | 0.100 |
Why?
| | Chromosome Mapping | 8 | 2002 | 508 | 0.100 |
Why?
| | DNA Mutational Analysis | 2 | 2009 | 410 | 0.100 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2013 | 372 | 0.100 |
Why?
| | Receptors, Interleukin-7 | 2 | 2006 | 28 | 0.100 |
Why?
| | Conserved Sequence | 3 | 2009 | 242 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2003 | 2022 | 0.100 |
Why?
| | Kinetics | 13 | 2021 | 1553 | 0.100 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2013 | 16 | 0.100 |
Why?
| | Lymphocytes, Null | 1 | 2012 | 3 | 0.100 |
Why?
| | HLA-DR4 Antigen | 2 | 2005 | 74 | 0.090 |
Why?
| | Minor Histocompatibility Loci | 2 | 1990 | 3 | 0.090 |
Why?
| | Diphtheria Toxin | 1 | 2013 | 61 | 0.090 |
Why?
| | Antibodies, Viral | 1 | 2017 | 689 | 0.090 |
Why?
| | Age Factors | 4 | 2017 | 3347 | 0.090 |
Why?
| | Mice, Nude | 3 | 2013 | 668 | 0.090 |
Why?
| | Escherichia coli | 4 | 2013 | 832 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 334 | 0.090 |
Why?
| | Erythrocytes | 16 | 2002 | 750 | 0.090 |
Why?
| | Genes, Immunoglobulin | 3 | 1988 | 29 | 0.090 |
Why?
| | Cell Lineage | 2 | 2013 | 377 | 0.090 |
Why?
| | DNA Primers | 1 | 2013 | 487 | 0.090 |
Why?
| | Hemocyanins | 8 | 1983 | 61 | 0.090 |
Why?
| | Killer Cells, Natural | 2 | 2007 | 481 | 0.090 |
Why?
| | Rhadinovirus | 1 | 2012 | 20 | 0.090 |
Why?
| | Galactosylceramides | 2 | 2012 | 28 | 0.090 |
Why?
| | Tumor Virus Infections | 1 | 2012 | 51 | 0.090 |
Why?
| | Immunophenotyping | 3 | 2004 | 324 | 0.090 |
Why?
| | Burkitt Lymphoma | 1 | 2012 | 61 | 0.090 |
Why?
| | Haplotypes | 4 | 1990 | 506 | 0.090 |
Why?
| | Mice, Inbred CBA | 8 | 1991 | 56 | 0.090 |
Why?
| | Virus Diseases | 2 | 1992 | 219 | 0.090 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2012 | 74 | 0.090 |
Why?
| | Communicable Diseases | 1 | 1994 | 166 | 0.090 |
Why?
| | Immunologic Deficiency Syndromes | 3 | 2007 | 69 | 0.080 |
Why?
| | Ubiquitination | 2 | 2008 | 119 | 0.080 |
Why?
| | Nucleocapsid Proteins | 1 | 2011 | 28 | 0.080 |
Why?
| | Viral Core Proteins | 1 | 2011 | 21 | 0.080 |
Why?
| | Resting Phase, Cell Cycle | 1 | 2011 | 16 | 0.080 |
Why?
| | Receptors, Lymphocyte Homing | 1 | 2011 | 15 | 0.080 |
Why?
| | Surface Plasmon Resonance | 3 | 2021 | 87 | 0.080 |
Why?
| | Salts | 1 | 2010 | 34 | 0.080 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 7 | 2011 | 326 | 0.080 |
Why?
| | Orthomyxoviridae Infections | 1 | 2011 | 72 | 0.080 |
Why?
| | Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2010 | 8 | 0.080 |
Why?
| | Bone Marrow | 2 | 2009 | 310 | 0.080 |
Why?
| | Antibody Specificity | 7 | 1997 | 181 | 0.080 |
Why?
| | Structure-Activity Relationship | 8 | 2006 | 563 | 0.080 |
Why?
| | HLA-DP Antigens | 1 | 2010 | 32 | 0.080 |
Why?
| | Cattle | 2 | 2011 | 940 | 0.080 |
Why?
| | Species Specificity | 10 | 2006 | 543 | 0.080 |
Why?
| | Immunoprecipitation | 2 | 2008 | 150 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 902 | 0.080 |
Why?
| | Recombinant Proteins | 7 | 2005 | 1361 | 0.080 |
Why?
| | Fibrin | 1 | 2010 | 84 | 0.080 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 6 | 1999 | 26 | 0.080 |
Why?
| | Antigen-Antibody Reactions | 6 | 2021 | 50 | 0.080 |
Why?
| | Cell Line, Tumor | 4 | 2021 | 3545 | 0.080 |
Why?
| | Molecular Docking Simulation | 2 | 2021 | 121 | 0.070 |
Why?
| | France | 1 | 2009 | 40 | 0.070 |
Why?
| | Injections, Intraperitoneal | 1 | 2009 | 115 | 0.070 |
Why?
| | Antioxidants | 2 | 2003 | 544 | 0.070 |
Why?
| | Thrombin | 1 | 2010 | 175 | 0.070 |
Why?
| | Retroviridae | 2 | 2013 | 99 | 0.070 |
Why?
| | Aluminum Compounds | 1 | 2009 | 6 | 0.070 |
Why?
| | Fibrinogen | 1 | 2010 | 182 | 0.070 |
Why?
| | Phosphorylation | 4 | 2020 | 1724 | 0.070 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2009 | 22 | 0.070 |
Why?
| | Immunoglobulin Class Switching | 1 | 2009 | 21 | 0.070 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2011 | 268 | 0.070 |
Why?
| | CD4-CD8 Ratio | 2 | 2002 | 23 | 0.070 |
Why?
| | Antibody Affinity | 3 | 2005 | 60 | 0.070 |
Why?
| | Integrin alpha4 | 1 | 2008 | 7 | 0.070 |
Why?
| | Cell Adhesion Molecules | 1 | 1990 | 180 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2008 | 14 | 0.070 |
Why?
| | Adsorption | 1 | 2009 | 154 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 3 | 2004 | 382 | 0.070 |
Why?
| | Cytoskeletal Proteins | 1 | 2009 | 146 | 0.070 |
Why?
| | History, 21st Century | 1 | 2009 | 224 | 0.070 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2008 | 25 | 0.070 |
Why?
| | Genes, Switch | 1 | 1988 | 6 | 0.070 |
Why?
| | Chondroitin | 1 | 1988 | 6 | 0.070 |
Why?
| | Genes, Regulator | 1 | 1988 | 34 | 0.070 |
Why?
| | Antigens, Helminth | 1 | 2008 | 16 | 0.070 |
Why?
| | Histocompatibility Antigen H-2D | 3 | 2010 | 20 | 0.070 |
Why?
| | Influenza Vaccines | 1 | 2013 | 544 | 0.070 |
Why?
| | Chondroitin Sulfates | 1 | 1988 | 35 | 0.070 |
Why?
| | Methylation | 3 | 2018 | 241 | 0.070 |
Why?
| | Schistosoma mansoni | 1 | 2008 | 45 | 0.070 |
Why?
| | Biomarkers | 1 | 2019 | 4340 | 0.070 |
Why?
| | Protein Domains | 2 | 2020 | 315 | 0.070 |
Why?
| | Polymerase Chain Reaction | 6 | 1997 | 1031 | 0.070 |
Why?
| | Aged, 80 and over | 1 | 2020 | 8391 | 0.070 |
Why?
| | Mice, Inbred AKR | 10 | 1989 | 35 | 0.070 |
Why?
| | Transplantation Chimera | 3 | 2014 | 57 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 5 | 2002 | 663 | 0.070 |
Why?
| | Hybrid Cells | 4 | 1997 | 47 | 0.070 |
Why?
| | Liposomes | 3 | 2005 | 269 | 0.070 |
Why?
| | Biosensing Techniques | 1 | 2009 | 143 | 0.060 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2007 | 35 | 0.060 |
Why?
| | Fluoresceins | 2 | 2004 | 48 | 0.060 |
Why?
| | Pancreas | 2 | 2021 | 343 | 0.060 |
Why?
| | Infection Control | 1 | 2009 | 174 | 0.060 |
Why?
| | Immunoglobulin Fab Fragments | 2 | 2006 | 55 | 0.060 |
Why?
| | Moths | 3 | 1997 | 45 | 0.060 |
Why?
| | In Vitro Techniques | 8 | 2000 | 1041 | 0.060 |
Why?
| | RNA-Binding Proteins | 1 | 2011 | 465 | 0.060 |
Why?
| | Aged | 3 | 2020 | 26432 | 0.060 |
Why?
| | Arthritis, Rheumatoid | 3 | 2005 | 1185 | 0.060 |
Why?
| | Early Growth Response Protein 2 | 2 | 2018 | 10 | 0.060 |
Why?
| | Chemokines | 1 | 2007 | 217 | 0.060 |
Why?
| | Health | 1 | 2007 | 81 | 0.060 |
Why?
| | Poly I-C | 1 | 2006 | 58 | 0.060 |
Why?
| | B-Cell Activating Factor | 1 | 2006 | 21 | 0.060 |
Why?
| | Arginine | 2 | 2018 | 264 | 0.060 |
Why?
| | Chemotaxis, Leukocyte | 2 | 2003 | 115 | 0.060 |
Why?
| | Hyaluronan Receptors | 3 | 2003 | 105 | 0.060 |
Why?
| | Transgenes | 2 | 1997 | 178 | 0.060 |
Why?
| | Tissue Distribution | 3 | 1993 | 334 | 0.060 |
Why?
| | Leukopoiesis | 1 | 2006 | 11 | 0.060 |
Why?
| | Spodoptera | 2 | 2021 | 39 | 0.060 |
Why?
| | Peptide Hydrolases | 1 | 2006 | 105 | 0.060 |
Why?
| | Caspases | 2 | 2014 | 233 | 0.060 |
Why?
| | Promoter Regions, Genetic | 4 | 2020 | 1242 | 0.060 |
Why?
| | Cell Fusion | 4 | 1989 | 47 | 0.060 |
Why?
| | Enzyme Activation | 3 | 2008 | 759 | 0.060 |
Why?
| | Protein Structure, Secondary | 4 | 2012 | 357 | 0.060 |
Why?
| | HLA-D Antigens | 2 | 1998 | 30 | 0.060 |
Why?
| | Insulin-Secreting Cells | 1 | 2010 | 393 | 0.060 |
Why?
| | Prostaglandins E | 1 | 1985 | 33 | 0.050 |
Why?
| | Sheep | 11 | 1983 | 870 | 0.050 |
Why?
| | Leukemia P388 | 2 | 1984 | 7 | 0.050 |
Why?
| | Lymphocyte Depletion | 4 | 2001 | 135 | 0.050 |
Why?
| | Succinimides | 1 | 2004 | 21 | 0.050 |
Why?
| | Proteolysis | 2 | 2018 | 174 | 0.050 |
Why?
| | Models, Biological | 3 | 2001 | 1761 | 0.050 |
Why?
| | Phosphatidylserines | 1 | 2005 | 62 | 0.050 |
Why?
| | Whole-Body Irradiation | 2 | 2013 | 73 | 0.050 |
Why?
| | MAP Kinase Kinase Kinases | 2 | 2008 | 70 | 0.050 |
Why?
| | Immunoglobulin Allotypes | 1 | 1984 | 9 | 0.050 |
Why?
| | Tumor Cells, Cultured | 4 | 2001 | 882 | 0.050 |
Why?
| | Vaccinia virus | 2 | 2001 | 35 | 0.050 |
Why?
| | Plasmids | 4 | 2001 | 373 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2004 | 269 | 0.050 |
Why?
| | B-Cell CLL-Lymphoma 10 Protein | 1 | 2004 | 3 | 0.050 |
Why?
| | Phosphoserine | 1 | 2004 | 25 | 0.050 |
Why?
| | Antigens, Differentiation | 2 | 1997 | 75 | 0.050 |
Why?
| | Leukemia, Experimental | 1 | 1983 | 26 | 0.050 |
Why?
| | Receptors, Leukotriene B4 | 1 | 2003 | 7 | 0.050 |
Why?
| | Fetus | 4 | 2014 | 800 | 0.050 |
Why?
| | Sex Factors | 1 | 2010 | 2107 | 0.050 |
Why?
| | Leukotriene B4 | 1 | 2003 | 37 | 0.050 |
Why?
| | Catalase | 1 | 2003 | 133 | 0.050 |
Why?
| | Luminescent Proteins | 2 | 2001 | 188 | 0.050 |
Why?
| | Young Adult | 1 | 2020 | 14330 | 0.050 |
Why?
| | Lung | 4 | 2014 | 4122 | 0.050 |
Why?
| | Fibroblasts | 3 | 2017 | 1034 | 0.050 |
Why?
| | Chromosome Deletion | 4 | 1991 | 127 | 0.050 |
Why?
| | Bone Marrow Transplantation | 3 | 2014 | 301 | 0.050 |
Why?
| | Antibody-Producing Cells | 7 | 1983 | 30 | 0.050 |
Why?
| | Fas Ligand Protein | 1 | 2003 | 61 | 0.050 |
Why?
| | Myeloid Cells | 1 | 2004 | 149 | 0.050 |
Why?
| | RNA | 3 | 2003 | 926 | 0.050 |
Why?
| | Selection, Genetic | 2 | 2019 | 269 | 0.050 |
Why?
| | Incidence | 1 | 2010 | 2936 | 0.050 |
Why?
| | Solubility | 4 | 1998 | 240 | 0.050 |
Why?
| | Interleukin-1 | 5 | 1997 | 960 | 0.050 |
Why?
| | Binding Sites, Antibody | 5 | 1991 | 41 | 0.050 |
Why?
| | Fluorescent Dyes | 2 | 2001 | 340 | 0.050 |
Why?
| | Antigens, Ly | 4 | 1988 | 46 | 0.050 |
Why?
| | Protein Biosynthesis | 3 | 1992 | 449 | 0.040 |
Why?
| | Vaccines, Synthetic | 1 | 2022 | 138 | 0.040 |
Why?
| | Sequence Alignment | 2 | 2008 | 360 | 0.040 |
Why?
| | Mesencephalon | 1 | 2002 | 65 | 0.040 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2002 | 195 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2002 | 162 | 0.040 |
Why?
| | Synovial Fluid | 2 | 2000 | 69 | 0.040 |
Why?
| | Sf9 Cells | 1 | 2021 | 11 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2002 | 165 | 0.040 |
Why?
| | Chronic Disease | 3 | 2013 | 1827 | 0.040 |
Why?
| | Crystallization | 2 | 2015 | 131 | 0.040 |
Why?
| | Interphase | 2 | 2000 | 38 | 0.040 |
Why?
| | Calcium | 6 | 2004 | 1181 | 0.040 |
Why?
| | Sex Chromosome Aberrations | 1 | 1981 | 67 | 0.040 |
Why?
| | Hemolytic Plaque Technique | 10 | 1983 | 28 | 0.040 |
Why?
| | CD40 Antigens | 1 | 2001 | 69 | 0.040 |
Why?
| | Growth Inhibitors | 1 | 2001 | 39 | 0.040 |
Why?
| | Saccharomyces cerevisiae | 1 | 2005 | 584 | 0.040 |
Why?
| | Borrelia burgdorferi Group | 1 | 2000 | 7 | 0.040 |
Why?
| | Melanoma, Experimental | 1 | 2001 | 106 | 0.040 |
Why?
| | Phagocytosis | 1 | 2002 | 298 | 0.040 |
Why?
| | Up-Regulation | 1 | 2003 | 841 | 0.040 |
Why?
| | Temperature | 1 | 2003 | 635 | 0.040 |
Why?
| | Nucleic Acid Hybridization | 2 | 1999 | 175 | 0.040 |
Why?
| | Receptors, Interleukin-15 | 1 | 2000 | 3 | 0.040 |
Why?
| | Receptors, Virus | 1 | 2021 | 91 | 0.040 |
Why?
| | Phorbol Esters | 1 | 2000 | 13 | 0.040 |
Why?
| | Antibody Diversity | 3 | 1989 | 16 | 0.040 |
Why?
| | Suppressor of Cytokine Signaling 1 Protein | 1 | 2000 | 12 | 0.040 |
Why?
| | Lymphocyte Culture Test, Mixed | 3 | 1990 | 49 | 0.040 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2000 | 58 | 0.040 |
Why?
| | Expressed Sequence Tags | 1 | 2000 | 43 | 0.040 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 1 | 2000 | 20 | 0.040 |
Why?
| | Immunosuppressive Agents | 1 | 2005 | 829 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2021 | 145 | 0.040 |
Why?
| | Jurkat Cells | 1 | 2000 | 115 | 0.040 |
Why?
| | Haploidy | 1 | 1980 | 30 | 0.040 |
Why?
| | Receptors, Interleukin-6 | 1 | 2000 | 49 | 0.040 |
Why?
| | STAT1 Transcription Factor | 1 | 2000 | 68 | 0.040 |
Why?
| | Cancer Vaccines | 1 | 2021 | 161 | 0.040 |
Why?
| | Indicators and Reagents | 1 | 2000 | 105 | 0.040 |
Why?
| | Cell Line, Transformed | 1 | 2000 | 137 | 0.040 |
Why?
| | Lymphocyte Transfusion | 1 | 1999 | 20 | 0.040 |
Why?
| | Leukemia L1210 | 1 | 1999 | 7 | 0.040 |
Why?
| | Rats | 5 | 2002 | 5586 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 122 | 0.040 |
Why?
| | Lipoproteins | 1 | 2000 | 165 | 0.040 |
Why?
| | DNA-Binding Proteins | 2 | 2012 | 1468 | 0.040 |
Why?
| | Lymphopenia | 1 | 1999 | 62 | 0.040 |
Why?
| | Haptens | 3 | 1988 | 25 | 0.040 |
Why?
| | Recombination, Genetic | 4 | 1988 | 202 | 0.040 |
Why?
| | Free Radical Scavengers | 1 | 1999 | 81 | 0.040 |
Why?
| | Chickens | 5 | 1994 | 169 | 0.040 |
Why?
| | Peer Review, Research | 1 | 1999 | 36 | 0.040 |
Why?
| | Manganese | 1 | 1999 | 59 | 0.040 |
Why?
| | Metalloporphyrins | 1 | 1999 | 62 | 0.040 |
Why?
| | Cholic Acids | 1 | 1998 | 13 | 0.040 |
Why?
| | HIV Envelope Protein gp120 | 1 | 1999 | 55 | 0.040 |
Why?
| | Middle Aged | 2 | 2020 | 36619 | 0.040 |
Why?
| | Detergents | 1 | 1998 | 42 | 0.040 |
Why?
| | Cell Cycle | 2 | 2020 | 595 | 0.030 |
Why?
| | National Institutes of Health (U.S.) | 1 | 1999 | 147 | 0.030 |
Why?
| | Coculture Techniques | 2 | 2013 | 245 | 0.030 |
Why?
| | Trinitrobenzenes | 5 | 1982 | 14 | 0.030 |
Why?
| | Membrane Potentials | 1 | 1999 | 278 | 0.030 |
Why?
| | Oligodeoxyribonucleotides | 2 | 2005 | 141 | 0.030 |
Why?
| | Nucleosomes | 1 | 2020 | 168 | 0.030 |
Why?
| | Adult | 3 | 2020 | 41087 | 0.030 |
Why?
| | Behavior, Animal | 1 | 2002 | 531 | 0.030 |
Why?
| | STAT3 Transcription Factor | 1 | 2000 | 214 | 0.030 |
Why?
| | DNA Repair | 1 | 2020 | 255 | 0.030 |
Why?
| | Crystallography | 2 | 2007 | 26 | 0.030 |
Why?
| | Mice, Inbred A | 6 | 1984 | 47 | 0.030 |
Why?
| | Neutrophils | 1 | 2004 | 1133 | 0.030 |
Why?
| | NFATC Transcription Factors | 1 | 2018 | 93 | 0.030 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 103 | 0.030 |
Why?
| | Hot Temperature | 2 | 2000 | 396 | 0.030 |
Why?
| | Autophagosomes | 1 | 2017 | 20 | 0.030 |
Why?
| | Endocytosis | 1 | 1998 | 170 | 0.030 |
Why?
| | Nicotinic Antagonists | 1 | 2017 | 37 | 0.030 |
Why?
| | STAT6 Transcription Factor | 1 | 1997 | 25 | 0.030 |
Why?
| | Neoplasm Transplantation | 2 | 2012 | 238 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 1999 | 307 | 0.030 |
Why?
| | Dinoprostone | 2 | 1991 | 179 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 366 | 0.030 |
Why?
| | Lymphoma | 5 | 1985 | 251 | 0.030 |
Why?
| | Recovery of Function | 1 | 2002 | 725 | 0.030 |
Why?
| | Oligonucleotides | 2 | 2004 | 155 | 0.030 |
Why?
| | Interleukins | 1 | 1999 | 248 | 0.030 |
Why?
| | Abatacept | 1 | 1997 | 56 | 0.030 |
Why?
| | Columbidae | 2 | 1994 | 31 | 0.030 |
Why?
| | Mutagenesis | 2 | 2013 | 196 | 0.030 |
Why?
| | Receptors, Complement | 1 | 2017 | 126 | 0.030 |
Why?
| | Phylogeny | 1 | 2021 | 924 | 0.030 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2017 | 66 | 0.030 |
Why?
| | Immunomodulation | 1 | 2017 | 98 | 0.030 |
Why?
| | Societies, Medical | 1 | 2001 | 907 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 1997 | 297 | 0.030 |
Why?
| | Protein Subunits | 1 | 2017 | 225 | 0.030 |
Why?
| | Gene Deletion | 2 | 2009 | 385 | 0.030 |
Why?
| | Respiratory Hypersensitivity | 1 | 1997 | 65 | 0.030 |
Why?
| | CTLA-4 Antigen | 1 | 1997 | 105 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 1998 | 185 | 0.030 |
Why?
| | Germ-Line Mutation | 2 | 2009 | 180 | 0.030 |
Why?
| | Genetic Complementation Test | 2 | 1986 | 72 | 0.030 |
Why?
| | Molecular Conformation | 2 | 2009 | 141 | 0.030 |
Why?
| | Immunity, Mucosal | 1 | 1997 | 97 | 0.030 |
Why?
| | Hemolysis | 1 | 2017 | 242 | 0.030 |
Why?
| | Sequence Homology | 1 | 1995 | 43 | 0.030 |
Why?
| | Nitrophenols | 4 | 2004 | 30 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2003 | 534 | 0.030 |
Why?
| | Molecular Structure | 2 | 2003 | 484 | 0.030 |
Why?
| | Epitope Mapping | 2 | 2011 | 61 | 0.030 |
Why?
| | Immunoglobulins | 2 | 1987 | 162 | 0.030 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2012 | 21 | 0.030 |
Why?
| | Histocompatibility Testing | 1 | 2015 | 124 | 0.030 |
Why?
| | Parkinson Disease | 1 | 2002 | 614 | 0.030 |
Why?
| | Autophagy | 1 | 2017 | 290 | 0.030 |
Why?
| | Immunoglobulin E | 2 | 1997 | 315 | 0.030 |
Why?
| | gamma-Globulins | 4 | 1983 | 14 | 0.030 |
Why?
| | Antilymphocyte Serum | 8 | 1981 | 55 | 0.030 |
Why?
| | Receptors, Nicotinic | 1 | 2017 | 337 | 0.030 |
Why?
| | Protein Transport | 2 | 2008 | 443 | 0.030 |
Why?
| | Insecta | 2 | 2006 | 73 | 0.030 |
Why?
| | V(D)J Recombination | 1 | 2014 | 8 | 0.030 |
Why?
| | Peptide Biosynthesis | 1 | 1994 | 13 | 0.030 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2008 | 153 | 0.030 |
Why?
| | Enzyme-Linked Immunospot Assay | 1 | 2014 | 40 | 0.030 |
Why?
| | Cell Adhesion | 3 | 1999 | 447 | 0.030 |
Why?
| | Gene Dosage | 1 | 2014 | 146 | 0.030 |
Why?
| | Databases, Factual | 1 | 2000 | 1493 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 447 | 0.030 |
Why?
| | Cysteine | 2 | 2010 | 210 | 0.030 |
Why?
| | Transplantation, Homologous | 1 | 2015 | 416 | 0.030 |
Why?
| | Disulfides | 2 | 1984 | 93 | 0.030 |
Why?
| | Transferrin | 1 | 1993 | 48 | 0.020 |
Why?
| | Transplantation Immunology | 1 | 1993 | 28 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2011 | 371 | 0.020 |
Why?
| | Cell Transplantation | 1 | 1993 | 39 | 0.020 |
Why?
| | Multigene Family | 2 | 1991 | 210 | 0.020 |
Why?
| | Trypsin | 4 | 2006 | 73 | 0.020 |
Why?
| | Sodium | 1 | 2014 | 196 | 0.020 |
Why?
| | Hydrogen Bonding | 2 | 2008 | 170 | 0.020 |
Why?
| | Horses | 4 | 1981 | 229 | 0.020 |
Why?
| | Endopeptidase K | 1 | 2013 | 17 | 0.020 |
Why?
| | Viral Envelope Proteins | 1 | 1994 | 97 | 0.020 |
Why?
| | Growth Substances | 2 | 1983 | 136 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2014 | 209 | 0.020 |
Why?
| | Blotting, Southern | 1 | 1993 | 82 | 0.020 |
Why?
| | Fetal Tissue Transplantation | 1 | 1992 | 33 | 0.020 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2013 | 23 | 0.020 |
Why?
| | HLA-DR Serological Subtypes | 1 | 2012 | 4 | 0.020 |
Why?
| | Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2012 | 31 | 0.020 |
Why?
| | Hepatocytes | 1 | 2014 | 224 | 0.020 |
Why?
| | Vomiting | 1 | 1993 | 131 | 0.020 |
Why?
| | United States | 3 | 2015 | 16136 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 712 | 0.020 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2012 | 37 | 0.020 |
Why?
| | Embryonic and Fetal Development | 1 | 1992 | 90 | 0.020 |
Why?
| | Disease | 1 | 1993 | 97 | 0.020 |
Why?
| | Perissodactyla | 4 | 1981 | 13 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2012 | 131 | 0.020 |
Why?
| | Immunoassay | 2 | 1989 | 108 | 0.020 |
Why?
| | Ionomycin | 1 | 1991 | 22 | 0.020 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 1991 | 128 | 0.020 |
Why?
| | DNA, Recombinant | 3 | 2005 | 46 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2014 | 1298 | 0.020 |
Why?
| | Oligonucleotides, Antisense | 1 | 1992 | 122 | 0.020 |
Why?
| | Genotype | 1 | 1996 | 1879 | 0.020 |
Why?
| | Receptors, Natural Killer Cell | 1 | 2011 | 16 | 0.020 |
Why?
| | DNA Methylation | 1 | 1996 | 725 | 0.020 |
Why?
| | Intestinal Mucosa | 1 | 1997 | 666 | 0.020 |
Why?
| | Mice, Inbred NZB | 2 | 2007 | 16 | 0.020 |
Why?
| | Tumor Burden | 1 | 2012 | 326 | 0.020 |
Why?
| | Blotting, Northern | 1 | 1991 | 197 | 0.020 |
Why?
| | Glycosylation | 4 | 1994 | 177 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 1992 | 319 | 0.020 |
Why?
| | Mutant Chimeric Proteins | 1 | 2010 | 5 | 0.020 |
Why?
| | Cellular Senescence | 1 | 1993 | 225 | 0.020 |
Why?
| | Milk | 1 | 1991 | 117 | 0.020 |
Why?
| | Receptors, Leukocyte-Adhesion | 1 | 1990 | 2 | 0.020 |
Why?
| | Depression, Chemical | 1 | 1990 | 16 | 0.020 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 1990 | 9 | 0.020 |
Why?
| | Smoking | 1 | 2017 | 1486 | 0.020 |
Why?
| | Lysine | 1 | 2012 | 303 | 0.020 |
Why?
| | Epoprostenol | 1 | 1991 | 132 | 0.020 |
Why?
| | Oligonucleotide Probes | 1 | 1990 | 48 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 52 | 0.020 |
Why?
| | Amidohydrolases | 1 | 1990 | 31 | 0.020 |
Why?
| | RNA Splicing | 1 | 1991 | 288 | 0.020 |
Why?
| | Restriction Mapping | 3 | 1998 | 80 | 0.020 |
Why?
| | Pregnancy | 2 | 2014 | 7230 | 0.020 |
Why?
| | Immunotherapy, Adoptive | 1 | 1993 | 356 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2011 | 168 | 0.020 |
Why?
| | Histidine | 2 | 2003 | 67 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2014 | 428 | 0.020 |
Why?
| | Precipitin Tests | 2 | 1991 | 90 | 0.020 |
Why?
| | Immunoglobulin Joining Region | 1 | 1988 | 10 | 0.020 |
Why?
| | Leukemia, Lymphoid | 2 | 2006 | 27 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2013 | 533 | 0.020 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 1 | 2008 | 15 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 525 | 0.020 |
Why?
| | Homozygote | 1 | 1989 | 197 | 0.020 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 1 | 2008 | 46 | 0.020 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2008 | 45 | 0.020 |
Why?
| | Eosinophils | 2 | 2004 | 319 | 0.020 |
Why?
| | Gestational Age | 1 | 1992 | 990 | 0.020 |
Why?
| | Caspase Inhibitors | 1 | 2008 | 81 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2008 | 147 | 0.020 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 1988 | 38 | 0.020 |
Why?
| | Immune Sera | 2 | 2005 | 77 | 0.020 |
Why?
| | Immunoblotting | 1 | 2008 | 294 | 0.020 |
Why?
| | Microspheres | 1 | 1988 | 142 | 0.020 |
Why?
| | Nitrobenzenes | 3 | 1976 | 15 | 0.020 |
Why?
| | Shock, Septic | 1 | 1990 | 230 | 0.020 |
Why?
| | Animals, Newborn | 2 | 1988 | 888 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 106 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 2008 | 103 | 0.020 |
Why?
| | Glutamic Acid | 1 | 2010 | 255 | 0.020 |
Why?
| | Mice, Congenic | 1 | 2007 | 23 | 0.020 |
Why?
| | Leukocyte Count | 1 | 1988 | 321 | 0.020 |
Why?
| | Antigens, CD1 | 1 | 2007 | 59 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2002 | 11821 | 0.020 |
Why?
| | Biological Transport | 2 | 1999 | 424 | 0.020 |
Why?
| | Epithelial Cells | 1 | 1993 | 1119 | 0.020 |
Why?
| | Cytoplasm | 2 | 2004 | 253 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2006 | 51 | 0.020 |
Why?
| | Immunoglobulin gamma-Chains | 1 | 1986 | 2 | 0.020 |
Why?
| | Antibodies, Antinuclear | 1 | 2006 | 60 | 0.020 |
Why?
| | Antigens, T-Independent | 2 | 1983 | 5 | 0.010 |
Why?
| | Proteinuria | 1 | 2006 | 103 | 0.010 |
Why?
| | Glass | 1 | 1986 | 46 | 0.010 |
Why?
| | Proteins | 2 | 1982 | 1022 | 0.010 |
Why?
| | Weight Loss | 1 | 1992 | 858 | 0.010 |
Why?
| | Liver Transplantation | 1 | 1992 | 751 | 0.010 |
Why?
| | Kidney Glomerulus | 1 | 2006 | 129 | 0.010 |
Why?
| | Liver | 2 | 1992 | 1864 | 0.010 |
Why?
| | Body Weight | 1 | 1990 | 968 | 0.010 |
Why?
| | Transformation, Genetic | 1 | 1985 | 14 | 0.010 |
Why?
| | Mast-Cell Sarcoma | 1 | 1985 | 9 | 0.010 |
Why?
| | Cricetinae | 3 | 1994 | 296 | 0.010 |
Why?
| | Stereoisomerism | 1 | 2005 | 102 | 0.010 |
Why?
| | Injections, Subcutaneous | 1 | 2005 | 170 | 0.010 |
Why?
| | Prevalence | 1 | 2012 | 2861 | 0.010 |
Why?
| | Freund's Adjuvant | 1 | 2004 | 17 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1984 | 316 | 0.010 |
Why?
| | Rosette Formation | 2 | 1980 | 14 | 0.010 |
Why?
| | Genetic Markers | 1 | 1985 | 340 | 0.010 |
Why?
| | Isoelectric Point | 1 | 1984 | 21 | 0.010 |
Why?
| | Isoelectric Focusing | 1 | 1983 | 30 | 0.010 |
Why?
| | Microtubule-Associated Proteins | 1 | 2005 | 187 | 0.010 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2004 | 132 | 0.010 |
Why?
| | Gene Library | 1 | 2004 | 121 | 0.010 |
Why?
| | Receptors, CCR5 | 1 | 2003 | 59 | 0.010 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 158 | 0.010 |
Why?
| | Chemical Precipitation | 1 | 1983 | 39 | 0.010 |
Why?
| | Rabbits | 3 | 1984 | 651 | 0.010 |
Why?
| | Birds | 1 | 1983 | 87 | 0.010 |
Why?
| | Karyotyping | 1 | 1983 | 106 | 0.010 |
Why?
| | Phosphates | 1 | 2004 | 175 | 0.010 |
Why?
| | Phosphoproteins | 1 | 2005 | 320 | 0.010 |
Why?
| | Lod Score | 1 | 2002 | 64 | 0.010 |
Why?
| | Oxidopamine | 1 | 2002 | 14 | 0.010 |
Why?
| | Ubiquitin C | 1 | 2001 | 3 | 0.010 |
Why?
| | Sympatholytics | 1 | 2002 | 11 | 0.010 |
Why?
| | Transplantation, Heterotopic | 1 | 2002 | 16 | 0.010 |
Why?
| | DNA, Viral | 1 | 2004 | 354 | 0.010 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2002 | 72 | 0.010 |
Why?
| | Interleukin-5 | 1 | 1982 | 39 | 0.010 |
Why?
| | X Chromosome | 1 | 1981 | 66 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2004 | 441 | 0.010 |
Why?
| | DNA Restriction Enzymes | 3 | 1986 | 46 | 0.010 |
Why?
| | Immunoglobulin Constant Regions | 3 | 1986 | 7 | 0.010 |
Why?
| | Thymectomy | 3 | 1975 | 15 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2004 | 771 | 0.010 |
Why?
| | Organ Specificity | 1 | 2001 | 307 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2001 | 275 | 0.010 |
Why?
| | Chromatography, Gel | 2 | 1983 | 131 | 0.010 |
Why?
| | Lyme Disease Vaccines | 1 | 2000 | 3 | 0.010 |
Why?
| | Methamphetamine | 1 | 2002 | 75 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2005 | 630 | 0.010 |
Why?
| | Biopolymers | 1 | 2000 | 31 | 0.010 |
Why?
| | Bacterial Vaccines | 1 | 2000 | 63 | 0.010 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2000 | 58 | 0.010 |
Why?
| | Corpus Striatum | 1 | 2002 | 181 | 0.010 |
Why?
| | HLA-DRB1 Chains | 1 | 2000 | 109 | 0.010 |
Why?
| | MAP Kinase Kinase Kinase 2 | 1 | 1999 | 12 | 0.010 |
Why?
| | Lyme Disease | 1 | 2000 | 58 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1999 | 95 | 0.010 |
Why?
| | Staining and Labeling | 1 | 1980 | 148 | 0.010 |
Why?
| | Androstadienes | 1 | 1999 | 77 | 0.010 |
Why?
| | Immunization, Secondary | 1 | 1999 | 94 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 134 | 0.010 |
Why?
| | Dopamine | 1 | 2002 | 295 | 0.010 |
Why?
| | Public Policy | 1 | 1999 | 79 | 0.010 |
Why?
| | Computer Simulation | 1 | 2003 | 1014 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 170 | 0.010 |
Why?
| | Half-Life | 2 | 1977 | 157 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 263 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 1999 | 288 | 0.010 |
Why?
| | Cartilage | 1 | 2000 | 198 | 0.010 |
Why?
| | Asparagine | 1 | 1998 | 34 | 0.010 |
Why?
| | Polysaccharides, Bacterial | 2 | 1975 | 70 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 1999 | 404 | 0.010 |
Why?
| | Histocompatibility | 1 | 1977 | 20 | 0.010 |
Why?
| | Codon | 1 | 1998 | 92 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2002 | 1712 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 1999 | 384 | 0.010 |
Why?
| | Collagen | 1 | 2000 | 460 | 0.010 |
Why?
| | Dimerization | 1 | 1997 | 174 | 0.010 |
Why?
| | Warfarin | 1 | 1978 | 179 | 0.010 |
Why?
| | Antigen-Antibody Complex | 2 | 1987 | 70 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2002 | 2537 | 0.010 |
Why?
| | Research | 1 | 1999 | 421 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 823 | 0.010 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 1996 | 76 | 0.010 |
Why?
| | Radiation Effects | 1 | 1975 | 7 | 0.010 |
Why?
| | Absorption | 1 | 1975 | 60 | 0.010 |
Why?
| | Mollusca | 1 | 1975 | 6 | 0.010 |
Why?
| | Surface Properties | 1 | 1976 | 384 | 0.010 |
Why?
| | Trachea | 1 | 1997 | 253 | 0.010 |
Why?
| | Biological Transport, Active | 1 | 1994 | 69 | 0.010 |
Why?
| | Endopeptidases | 1 | 1994 | 80 | 0.010 |
Why?
| | Golgi Apparatus | 1 | 1994 | 99 | 0.010 |
Why?
| | Umbilical Cord | 1 | 1994 | 92 | 0.010 |
Why?
| | Hemoglobins | 1 | 1996 | 384 | 0.010 |
Why?
| | Immunologic Techniques | 2 | 1983 | 36 | 0.010 |
Why?
| | Antibodies, Anti-Idiotypic | 2 | 1983 | 50 | 0.010 |
Why?
| | Pedigree | 1 | 1994 | 512 | 0.010 |
Why?
| | Macaca mulatta | 1 | 1993 | 188 | 0.010 |
Why?
| | Neurons | 1 | 2002 | 1668 | 0.010 |
Why?
| | Microsomes | 1 | 1992 | 33 | 0.010 |
Why?
| | Genetic Variation | 2 | 1990 | 996 | 0.010 |
Why?
| | Drug Synergism | 2 | 1983 | 354 | 0.010 |
Why?
| | Zinc | 1 | 1995 | 310 | 0.010 |
Why?
| | Models, Structural | 1 | 1991 | 40 | 0.010 |
Why?
| | Methionine | 1 | 1992 | 160 | 0.010 |
Why?
| | 6-Ketoprostaglandin F1 alpha | 1 | 1991 | 17 | 0.010 |
Why?
| | Calcimycin | 1 | 1991 | 36 | 0.010 |
Why?
| | Carbohydrates | 1 | 1991 | 66 | 0.010 |
Why?
| | Endothelium, Vascular | 1 | 1997 | 952 | 0.000 |
Why?
| | Arthritis | 1 | 1991 | 97 | 0.000 |
Why?
| | Genes, MHC Class I | 1 | 1990 | 37 | 0.000 |
Why?
| | Deoxyribonuclease HpaII | 1 | 1988 | 2 | 0.000 |
Why?
| | Deoxyribonuclease BamHI | 1 | 1988 | 3 | 0.000 |
Why?
| | Cricetulus | 1 | 1989 | 115 | 0.000 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 14 | 0.000 |
Why?
| | Phosphorylcholine | 1 | 1988 | 19 | 0.000 |
Why?
| | Reference Values | 1 | 1990 | 796 | 0.000 |
Why?
| | Extracellular Space | 1 | 1989 | 118 | 0.000 |
Why?
| | Cross-Linking Reagents | 1 | 1989 | 208 | 0.000 |
Why?
| | Bacteriophage lambda | 1 | 1988 | 89 | 0.000 |
Why?
| | Mannose | 1 | 1987 | 23 | 0.000 |
Why?
| | Hexosaminidases | 1 | 1987 | 17 | 0.000 |
Why?
| | Introns | 1 | 1988 | 257 | 0.000 |
Why?
| | Exons | 1 | 1988 | 361 | 0.000 |
Why?
| | Oligosaccharides | 1 | 1987 | 62 | 0.000 |
Why?
| | Enhancer Elements, Genetic | 1 | 1988 | 190 | 0.000 |
Why?
| | Pepsin A | 1 | 1986 | 18 | 0.000 |
Why?
| | Hypersensitivity, Delayed | 2 | 1978 | 30 | 0.000 |
Why?
| | Vinblastine | 2 | 1976 | 75 | 0.000 |
Why?
| | Staphylococcal Infections | 1 | 1990 | 397 | 0.000 |
Why?
| | Immunoglobulin J-Chains | 1 | 1985 | 6 | 0.000 |
Why?
| | Immunoenzyme Techniques | 1 | 1985 | 197 | 0.000 |
Why?
| | Bacteria | 1 | 1991 | 766 | 0.000 |
Why?
| | Genetic Code | 1 | 1985 | 24 | 0.000 |
Why?
| | Protein Denaturation | 1 | 1984 | 76 | 0.000 |
Why?
| | Immunoglobulin Light Chains | 1 | 1984 | 52 | 0.000 |
Why?
| | Membranes, Artificial | 1 | 1984 | 67 | 0.000 |
Why?
| | Albumins | 1 | 1984 | 120 | 0.000 |
Why?
| | Thymus Neoplasms | 1 | 1984 | 30 | 0.000 |
Why?
| | Macrophage-Activating Factors | 1 | 1983 | 3 | 0.000 |
Why?
| | Fixatives | 1 | 1983 | 13 | 0.000 |
Why?
| | Glutaral | 1 | 1983 | 14 | 0.000 |
Why?
| | Cell-Free System | 1 | 1983 | 54 | 0.000 |
Why?
| | Receptors, Antigen | 1 | 1983 | 15 | 0.000 |
Why?
| | Longitudinal Studies | 1 | 1990 | 3017 | 0.000 |
Why?
| | Cell Nucleus | 1 | 1985 | 584 | 0.000 |
Why?
| | Fetal Blood | 1 | 1983 | 325 | 0.000 |
Why?
| | Pulmonary Alveoli | 1 | 1983 | 385 | 0.000 |
Why?
| | Polymers | 1 | 1983 | 488 | 0.000 |
Why?
| | Isoantigens | 1 | 1977 | 17 | 0.000 |
Why?
| | Skin Tests | 1 | 1975 | 94 | 0.000 |
Why?
| | Child | 1 | 1994 | 22693 | 0.000 |
Why?
| | Immunoglobulin M | 1 | 1975 | 284 | 0.000 |
Why?
|
|
Marrack's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|